Table 1.
Baseline characteristics by gender1
| Characteristics | Total (n = 392) | Men (n = 231, 59%) | Women (n = 161, 41%) | P value |
| Age, yr | 58 (51-63) | 57 (50-63) | 58 (52-63) | 0.51 |
| Race | 0.64 | |||
| Non-Hispanic Caucasian | 240 (61) | 142 (62) | 98 (61) | |
| Black | 9 (2) | 4 (2) | 5 (3) | |
| Hispanic | 105 (27) | 59 (26) | 46 (29) | |
| Asian | 16 (4) | 11 (5) | 5 (3) | |
| Other | 22 (6) | 15 (7) | 7 (4) | |
| Etiology | < 0.01 | |||
| HCV | 168 (43) | 112 (49) | 56 (35) | |
| Alcohol | 75 (19) | 53 (23) | 22 (14) | |
| NAFLD/NASH | 55 (14) | 24 (10) | 31 (19) | |
| Autoimmune2 | 59 (15) | 21 (9) | 38 (24) | |
| HBV | 3 (1) | 3 (1) | 0 (0) | |
| Other | 32 (8) | 18 (8) | 14 (9) | |
| BMI, kg/m2 | 28.5 (25.0-33.7) | 28.8 (25.3-34.1) | 28.0 (24.2-33.0) | 0.13 |
| Diabetes mellitus | 115 (29) | 71 (31) | 44 (27) | 0.47 |
| Coronary artery disease | 17 (4) | 14 (3) | 3 (2) | 0.05 |
| Hypertension | 153 (39) | 98 (42) | 55 (34) | 0.10 |
| Stroke | 7 (2) | 4 (2) | 3(2) | 0.92 |
| Dialysis | 16 (4) | 7 (3) | 9 (5) | 0.21 |
| MELDNa | 18 (15-22) | 18 (15-22) | 19 (15-23) | 0.13 |
| Albumin, g/dL | 3.0 (2.6-3.4) | 3.0 (2.6-3.4) | 3.1 (2.7-3.4) | 0.30 |
| Presence of ascites | 133 (34) | 77 (33) | 56 (35) | 0.77 |
| Numbers connection test, s | 41 (30-58) | 42 (32-58) | 40 (29-58) | 0.30 |
| Moderate/severe HE | 165 (42) | 98 (42) | 67 (42) | 0.87 |
| Frail | 62 (16) | 26 (16) | 26 (17) | 0.88 |
1
Data presented as n (%) or median (IQR).
2
Combined autoimmune hepatitis, primary sclerosing cholangitis, and primary biliary cholangitis.
IQR: Interquartile range; HCV: Hepatitis C; NAFLD: Non-alcoholic fatty liver disease; NASH: Non-alcoholic steatohepatitis; HBV: Hepatitis B; BMI: Body mass index; MELDNa: Model for end-stage liver disease with serum sodium; HE: Hepatic encephalopathy.